• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻 I 型黏膜内子宫内膜腺癌患者行保留子宫和/或卵巢手术的安全性:根据手术范围比较生存情况。

Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery.

机构信息

Department of Obstetrics and Gynecology, Bichat University Hospital, Paris, France.

出版信息

Fertil Steril. 2012 Nov;98(5):1229-35. doi: 10.1016/j.fertnstert.2012.07.1142. Epub 2012 Sep 6.

DOI:10.1016/j.fertnstert.2012.07.1142
PMID:22959452
Abstract

OBJECTIVE

To compare the survival of patients with grade 1 intramucous endometrial adenocarcinoma according to the extent of surgery.

DESIGN

Retrospective cohort study.

SETTING

Not applicable.

PATIENT(S): A cohort of 489 patients who were 40 years of age or younger with grade 1 intramucous endometrial adenocarcinoma.

INTERVENTION(S): The patients were divided into the following three groups: 101 patients who underwent uterine preservation, 184 patients who underwent ovarian preservation, and 204 patients who underwent hysterectomy with oophorectomy.

MAIN OUTCOME MEASURE(S): The demographics and survival rates were compared.

RESULT(S): In the multivariate analysis, no factors were associated with ovarian preservation. In the multivariate analysis, the factors that were associated with uterine preservation were a later year of diagnosis and young age. In a multivariate Cox model, ovarian and uterine preservation had no effect on either cancer-specific or overall survival.

CONCLUSION(S): In patients with grade 1 intramucous endometrial adenocarcinoma, uterine and ovarian preservation were not associated with an increase in cancer-related mortality. Longer follow-up is needed to confirm the safety of a conservative approach toward the ovaries and/or the uterus.

摘要

目的

比较不同手术范围的Ⅰ级黏膜内子宫内膜腺癌患者的生存情况。

设计

回顾性队列研究。

地点

不适用。

患者

40 岁及以下的Ⅰ级黏膜内子宫内膜腺癌患者队列,共 489 例。

干预

患者分为三组:101 例保留子宫、184 例保留卵巢、204 例行子宫切除术和卵巢切除术。

主要观察指标

比较患者的人口统计学特征和生存率。

结果

多因素分析显示,卵巢保留与任何因素均无关。多因素分析显示,与保留子宫相关的因素为诊断年限较晚和年龄较小。多因素 Cox 模型显示,卵巢和子宫保留对癌症特异性和总体生存率均无影响。

结论

对于Ⅰ级黏膜内子宫内膜腺癌患者,保留卵巢和/或子宫并不增加癌症相关死亡率。需要更长时间的随访来证实对卵巢和/或子宫采取保守治疗方法的安全性。

相似文献

1
Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery.年轻 I 型黏膜内子宫内膜腺癌患者行保留子宫和/或卵巢手术的安全性:根据手术范围比较生存情况。
Fertil Steril. 2012 Nov;98(5):1229-35. doi: 10.1016/j.fertnstert.2012.07.1142. Epub 2012 Sep 6.
2
Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis.早期子宫内膜癌年轻患者卵巢保留的安全性:回顾性研究和荟萃分析。
Fertil Steril. 2013 Sep;100(3):782-7. doi: 10.1016/j.fertnstert.2013.05.032. Epub 2013 Jul 3.
3
Safety of ovarian preservation in premenopausal women with endometrial cancer.绝经前子宫内膜癌患者保留卵巢的安全性
J Clin Oncol. 2009 Mar 10;27(8):1214-9. doi: 10.1200/JCO.2008.19.8150. Epub 2009 Jan 26.
4
Impact of Conservative Managements in Young Women With Grade 2 or 3 Endometrial Adenocarcinoma Confined to the Endometrium.保守治疗对局限于子宫内膜的2级或3级子宫内膜腺癌年轻女性的影响。
Int J Gynecol Cancer. 2017 Mar;27(3):493-499. doi: 10.1097/IGC.0000000000000895.
5
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
6
Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.早期子宫内膜癌患者行卵巢保留术的结局:韩国妇科肿瘤学组研究。
Gynecol Oncol. 2013 Nov;131(2):289-93. doi: 10.1016/j.ygyno.2013.08.024. Epub 2013 Aug 29.
7
Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.IA 期子宫内膜癌患者的生存情况;随访能否改变?一项前瞻性全国性丹麦调查。
Acta Obstet Gynecol Scand. 2012 Aug;91(8):976-82. doi: 10.1111/j.1600-0412.2012.01438.x. Epub 2012 Jun 18.
8
Fertility preservation in young women with epithelial ovarian cancer.上皮性卵巢癌年轻女性的生育力保存
Cancer. 2009 Sep 15;115(18):4118-26. doi: 10.1002/cncr.24461.
9
Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.Ⅰ期子宫内膜癌复发的时间模式与组织学危险因素的关系。
Eur J Surg Oncol. 2012 Feb;38(2):166-9. doi: 10.1016/j.ejso.2011.10.011. Epub 2011 Nov 6.
10
Ovarian preservation in stage I low-grade endometrial stromal sarcomas.Ⅰ期低级别子宫内膜间质肉瘤的卵巢保留
Obstet Gynecol. 2005 Dec;106(6):1304-8. doi: 10.1097/01.AOG.0000185511.91694.1e.

引用本文的文献

1
Cancer of the corpus uteri: A 2025 update.子宫体癌:2025年最新进展
Int J Gynaecol Obstet. 2025 Sep;171 Suppl 1:60-77. doi: 10.1002/ijgo.70326. Epub 2025 Jul 7.
2
Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment.基于分子病理学的子宫内膜癌治疗定制:现状及对全身和局部治疗的可能影响。
Int J Mol Sci. 2024 Jul 15;25(14):7742. doi: 10.3390/ijms25147742.
3
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
分子和病理数据指导子宫内膜样子宫内膜癌患者选择卵巢保留。
Int J Gynecol Cancer. 2024 May 6;34(5):697-704. doi: 10.1136/ijgc-2023-005194.
4
The crucial value of serum ferritin in assessing high-risk factors and prognosis for patients with endometrial carcinoma.血清铁蛋白在评估子宫内膜癌患者高危因素和预后中的关键价值。
BMC Womens Health. 2023 Aug 7;23(1):415. doi: 10.1186/s12905-023-02575-x.
5
Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation?子宫内膜癌的治疗与分子诊断升级——为子宫内膜保护带来新工具?
Int J Mol Sci. 2023 Jun 5;24(11):9780. doi: 10.3390/ijms24119780.
6
Demographic shifts associated with implementation of evidence-based guidelines for ovarian conservation in patients with endometrioid endometrial cancer.与子宫内膜样子宫内膜癌患者卵巢保留循证指南实施相关的人口结构变化。
Int J Gynecol Cancer. 2022 Sep 6;32(9):1141-1146. doi: 10.1136/ijgc-2022-003661.
7
The Preeminent Value of the Apparent Diffusion Coefficient in Assessing High-Risk Factors and Prognosis for Stage I Endometrial Carcinoma Patients.表观扩散系数在评估Ⅰ期子宫内膜癌患者高危因素及预后中的卓越价值
Front Oncol. 2022 Feb 16;12:820904. doi: 10.3389/fonc.2022.820904. eCollection 2022.
8
Cancer of the corpus uteri: 2021 update.子宫体癌:2021年更新
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):45-60. doi: 10.1002/ijgo.13866.
9
Patterns of utilization and outcome of ovarian conservation for young women with minimal-risk endometrial cancer.年轻低危型子宫内膜癌患者行卵巢保留的利用模式和结局。
Gynecol Oncol. 2019 Jul;154(1):45-52. doi: 10.1016/j.ygyno.2019.04.653. Epub 2019 Apr 26.
10
Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer.保留卵巢可提高早期子宫内膜癌年轻患者的总生存率。
Oncotarget. 2017 Jun 7;8(35):59940-59949. doi: 10.18632/oncotarget.18404. eCollection 2017 Aug 29.